Pediatric immunotherapy is the force that drives our program’s cancer treatment.
The Pediatric Immunotherapy Program (PIP) offers clinical trials to families looking
for immunotherapy options for their child with relapsed cancer.
The program has two main elements, a clinical element and a research element. Both
elements work together to provide compassionate, cutting edge cancer treatment. Due
to discoveries made by members of the research team,our physicians, nurse practitioners, and registered nurses are able to implement a pediatric
immunotherapy treatment option. Our program’s goal, here at Augusta University (AU), is to test
innovative new therapies that can stimulate the body’s own immune system to help attack
the tumor after conventional chemotherapy and radiation.
Pediatric Immunotherapy Program
1120 15th St., CN4123
Augusta, GA 30912
Georgia Cancer Center